Premium
Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non‐anticoagulated blood in vitro
Author(s) -
Andersson Jonas,
Sanchez Javier,
Ekdahl Kristiilsson,
Elgue Graciela,
Nilsson Bo,
Larsson Rolf
Publication year - 2003
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.10104
Subject(s) - heparin , complement system , materials science , antithrombin , biomaterial , extracorporeal , coagulation , whole blood , biomedical engineering , platelet , biophysics , chromatography , biochemistry , chemistry , immunology , nanotechnology , surgery , medicine , biology , antibody
Contact between blood and a biomaterial surface takes place in many applications and is known to activate the coagulation and complement systems. Heparin surface coatings have been shown to reduce blood activation upon contact with artificial surfaces. To establish the optimal heparin surface concentration, blood was incubated in a tubing loop model at 37°C. The tubing was coated with different surface concentrations of heparin and rotated at three different velocities. We demonstrate that the blood compatibility of a surface with regard to coagulation, complement, and platelet activation can be improved by increasing the heparin surface concentration in the 6–12 pmol antithrombin/cm 2 concentration interval. The binding of factor H is not influenced by the increased heparin surface concentration, suggesting that this factor is not the primary regulator of complement on heparin surfaces. In addition, the heparin coating has no effect on the complement activation that occurs on gas surfaces in extracorporeal circuits. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res 67A: 458–466, 2003